Last reviewed · How we verify
High-dose oxytocin — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
High-dose oxytocin (High-dose oxytocin) — Ohio State University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| High-dose oxytocin TARGET | High-dose oxytocin | Ohio State University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- High-dose oxytocin CI watch — RSS
- High-dose oxytocin CI watch — Atom
- High-dose oxytocin CI watch — JSON
- High-dose oxytocin alone — RSS
Cite this brief
Drug Landscape (2026). High-dose oxytocin — Competitive Intelligence Brief. https://druglandscape.com/ci/high-dose-oxytocin. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab